The Crysforma team develops regular methods for clients according to their solid-state property requirements Crysforma, the unit specialised in solid-state development at the Institute of Chemical Research of Catalonia (ICIQ-CERCA), creates and refines processes to make crystals that meet specific needs in their properties, with a primary focus on creating key components for pharmaceutical drugs. […]
CRYSFORMA: Polymorphism and crystallization, key issues in drug development according to international health security
Are you looking for a stable polymorph of your drug substance? Do you want to avoid any manufacturability, bioavailability or clinical outcome affection during your drug development or storage due to any unknown solid form conversion? Or even do you need to demonstrate to regulation authorities your valid results? Chemical substance exists in the solid […]